Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Dialysis With CARPEDIEM®: French Multicentric Experience in 25 Patients

Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality.

We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.

Inclusion criteria:

• Children and neonates including premature and low birth weight neonates
• Have a diagnosis of acute kidney injury, end stage renal disease, metabolic disease, electrolyte abnormality
• Require renal replacement therapy

Exclusion Criteria:

-Renal replacement therapy with another device than Carpediem machine